| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| 2 | 0 | 0 | 0 | 0 | 0 | 0 | |
| BREAST | 992 | 26 | 1357 | 94 | 1144 | 206 | 1254 |
| ERLYTX | 91 | 1 | 52 | 4 | 49 | 10 | 61 |
| GI | 193 | 4 | 209 | 15 | 183 | 29 | 177 |
| GU | 438 | 2 | 104 | 30 | 365 | 69 | 420 |
| LEUK | 142 | 4 | 209 | 14 | 170 | 27 | 164 |
| LUNG | 197 | 6 | 313 | 19 | 231 | 34 | 207 |
| LYMPH | 396 | 6 | 313 | 36 | 438 | 64 | 390 |
| MELAN | 282 | 1 | 52 | 2 | 24 | 2 | 12 |
| MMYEL | 161 | 4 | 209 | 5 | 61 | 16 | 97 |
| MULT | 22 | 3 | 157 | 7 | 85 | 15 | 91 |
| OTHER | 38 | 0 | 0 | 3 | 37 | 5 | 30 |
| PREV | 3 | 0 | 0 | 0 | 0 | 0 | 0 |
| SXQOL | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2959 | 57 | 2975 | 229 | 2787 | 477 | 2903 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| CCD | 119 | 8 | 417 | 15 | 183 | 33 | 201 |
| ERLYTX | 10 | 0 | 0 | 0 | 0 | 1 | 6 |
| LEUK | 669 | 15 | 783 | 47 | 572 | 105 | 639 |
| LUNG | 304 | 10 | 522 | 35 | 426 | 66 | 402 |
| LYMPH | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| OTHER | 38 | 2 | 104 | 6 | 73 | 12 | 73 |
| PEOLC | 128 | 5 | 261 | 19 | 231 | 37 | 225 |
| PREV | 214 | 7 | 365 | 22 | 268 | 44 | 268 |
| SURV | 19 | 0 | 0 | 3 | 37 | 6 | 37 |
| SXQOL | 577 | 10 | 522 | 48 | 584 | 102 | 621 |
| Total | 2079 | 57 | 2974 | 195 | 2374 | 406 | 2472 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| 2 | 0 | 0 | 0 | 0 | 0 | 0 | |
| BREAST | 992 | 26 | 1357 | 94 | 1144 | 206 | 1254 |
| CCD | 119 | 8 | 417 | 15 | 183 | 33 | 201 |
| ERLYTX | 101 | 1 | 52 | 4 | 49 | 11 | 67 |
| GI | 193 | 4 | 209 | 15 | 183 | 29 | 177 |
| GU | 438 | 2 | 104 | 30 | 365 | 69 | 420 |
| LEUK | 811 | 19 | 991 | 61 | 743 | 132 | 804 |
| LUNG | 501 | 16 | 835 | 54 | 657 | 100 | 609 |
| LYMPH | 397 | 6 | 313 | 36 | 438 | 64 | 390 |
| MELAN | 282 | 1 | 52 | 2 | 24 | 2 | 12 |
| MMYEL | 161 | 4 | 209 | 5 | 61 | 16 | 97 |
| MULT | 22 | 3 | 157 | 7 | 85 | 15 | 91 |
| OTHER | 76 | 2 | 104 | 9 | 110 | 17 | 103 |
| PEOLC | 128 | 5 | 261 | 19 | 231 | 37 | 225 |
| PREV | 217 | 7 | 365 | 22 | 268 | 44 | 268 |
| SURV | 19 | 0 | 0 | 3 | 37 | 6 | 37 |
| SXQOL | 579 | 10 | 522 | 48 | 584 | 102 | 621 |
| Total | 5038 | 114 | 5948 | 424 | 5162 | 883 | 5376 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| 2 | 0 | 0 | 0 | 0 | 0 | 0 | |
| BREAST | 609 | 15 | 783 | 59 | 718 | 132 | 804 |
| ERLYTX | 50 | 1 | 52 | 3 | 37 | 7 | 43 |
| GI | 141 | 3 | 157 | 12 | 146 | 23 | 140 |
| GU | 367 | 2 | 104 | 22 | 268 | 52 | 317 |
| LEUK | 89 | 4 | 209 | 11 | 134 | 17 | 103 |
| LUNG | 125 | 2 | 104 | 7 | 85 | 15 | 91 |
| LYMPH | 253 | 3 | 157 | 26 | 317 | 40 | 244 |
| MELAN | 177 | 1 | 52 | 2 | 24 | 2 | 12 |
| MMYEL | 104 | 4 | 209 | 5 | 61 | 9 | 55 |
| MULT | 8 | 1 | 52 | 2 | 24 | 5 | 30 |
| OTHER | 38 | 0 | 0 | 3 | 37 | 5 | 30 |
| PREV | 3 | 0 | 0 | 0 | 0 | 0 | 0 |
| SXQOL | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1968 | 36 | 1879 | 152 | 1851 | 307 | 1869 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| CCD | 106 | 7 | 365 | 14 | 170 | 28 | 170 |
| ERLYTX | 10 | 0 | 0 | 0 | 0 | 1 | 6 |
| LEUK | 305 | 6 | 313 | 24 | 292 | 48 | 292 |
| LUNG | 187 | 7 | 365 | 22 | 268 | 43 | 262 |
| LYMPH | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| OTHER | 37 | 1 | 52 | 5 | 61 | 11 | 67 |
| PEOLC | 91 | 4 | 209 | 15 | 183 | 30 | 183 |
| PREV | 213 | 6 | 313 | 21 | 256 | 43 | 262 |
| SURV | 19 | 0 | 0 | 3 | 37 | 6 | 37 |
| SXQOL | 388 | 6 | 313 | 30 | 365 | 62 | 377 |
| Total | 1357 | 37 | 1930 | 134 | 1632 | 272 | 1656 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| 2 | 0 | 0 | 0 | 0 | 0 | 0 | |
| BREAST | 792 | 18 | 939 | 69 | 840 | 162 | 986 |
| CCD | 134 | 4 | 209 | 14 | 170 | 35 | 213 |
| ERLYTX | 60 | 1 | 52 | 3 | 37 | 8 | 49 |
| GI | 146 | 2 | 104 | 11 | 134 | 26 | 158 |
| GU | 389 | 4 | 209 | 27 | 329 | 57 | 347 |
| LEUK | 394 | 10 | 522 | 35 | 426 | 65 | 396 |
| LUNG | 313 | 9 | 470 | 29 | 353 | 58 | 353 |
| LYMPH | 254 | 3 | 157 | 26 | 317 | 40 | 244 |
| MELAN | 177 | 1 | 52 | 2 | 24 | 2 | 12 |
| MMYEL | 100 | 4 | 209 | 5 | 61 | 9 | 55 |
| MULT | 22 | 1 | 52 | 2 | 24 | 7 | 43 |
| OTHER | 252 | 4 | 209 | 19 | 231 | 45 | 274 |
| PEOLC | 95 | 3 | 157 | 14 | 170 | 27 | 164 |
| PREV | 216 | 6 | 313 | 21 | 256 | 43 | 262 |
| SURV | 19 | 0 | 0 | 3 | 37 | 6 | 37 |
| SXQOL | 390 | 6 | 313 | 30 | 365 | 62 | 377 |
| Total | 3755 | 76 | 3967 | 310 | 3774 | 652 | 3970 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| BREAST | 840 | 18 | 939 | 74 | 901 | 163 | 992 |
| ERLYTX | 87 | 1 | 52 | 4 | 49 | 9 | 55 |
| GI | 108 | 1 | 52 | 8 | 97 | 17 | 103 |
| GU | 250 | 1 | 52 | 20 | 244 | 45 | 274 |
| LEUK | 108 | 1 | 52 | 9 | 110 | 20 | 122 |
| LUNG | 166 | 6 | 313 | 16 | 195 | 30 | 183 |
| LYMPH | 321 | 6 | 313 | 27 | 329 | 52 | 317 |
| MMYEL | 150 | 4 | 209 | 5 | 61 | 15 | 91 |
| MULT | 22 | 3 | 157 | 7 | 85 | 15 | 91 |
| Total | 2052 | 41 | 2139 | 170 | 2071 | 366 | 2228 |
| Inst. | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| Member | 1956 | 42 | 2191 | 181 | 2204 | 354 | 2155 |
| AFFIL | 119 | 5 | 261 | 15 | 183 | 28 | 170 |
| CCOP/NCORP | 1250 | 26 | 1357 | 90 | 1096 | 197 | 1199 |
| Non-SWOG | 1711 | 39 | 2035 | 136 | 1656 | 302 | 1838 |
| Total | 5036 | 112 | 5844 | 422 | 5139 | 881 | 5362 |
| ADMIN | STUDYID | STNAME | REGTYPE | Opened? | Open Date |
|---|---|---|---|---|---|
| MMYEL | S2005 | WM, Prev. Untreated, I/R +/- Venetoclax | 1 | T | 20-NOV-25 |
| ADMIN | STUDYID | STNAME | REGTYPE | Registrations |
|---|---|---|---|---|
| LEUK | MYELOMATCH | MSRP for the NCI myeloMATCH Clinical Trials | 1 | 15 |
| BREAST | S2212 | Breast, TNBC, Neoadj Chemo + Pembro | 1 | 13 |
| LUNG | LUNGMAP | NSCLC, Adv, Master | 1 | 10 |
| BREAST | S2206 | Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva | 1 | 10 |
| LUNG | LUNGMAP | NSCLC, Adv, Master | 2 | 7 |
| SXQOL | S2013 | I-CHECKIT: ICI toxicity risk prediction study | 1 | 6 |
| CCD | S1703 | Met Breast, STM-monitoring v Usual Care | 2 | 5 |
| BREAST | S2206 | Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva | 2 | 5 |
| BREAST | A012301 | Breast, Early Stg, Tamoxifen | 1 | 4 |
| PREV | NRGCC005 | Colon,Non-AdvancedAdenomas,Colonoscopy5v10yrs | 1 | 4 |
| SXQOL | S2205 | ICE COMPRESS: Reduction of CIPN from Taxanes | 1 | 4 |
| MMYEL | S2209 | MM, Newly Dx, VRd-R->R v DRd-R->R v DRD-DR->D | 1 | 4 |
| LYMPH | S2308 | FL, LTB, Mosunetuzumab vs Rituximab | 1 | 4 |
| PREV | A212102 | Blind Ref Set for Multicancer Early Detection | 1 | 3 |
| LUNG | S1800E | Non-Match: Docetaxel + Ramu +/- Cemiplimab | 1 | 3 |
| LUNG | S1827 | SCLC, MRI Surveillance +/- PCI | 1 | 3 |
| MULT | S2101 | Melan or HNSCC, Adv, Cabo + Nivo | 2 | 3 |
| MULT | S2101 | Melan or HNSCC, Adv, Cabo + Nivo | 1 | 3 |
| PEOLC | S2408 | Panc Fistula Prevention, Lanreotide | 1 | 3 |
| CCD | S2417CD | Colrec Surv, Follow-up w/ CTAC site | 1 | 3 |